CA1247082A - Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines - Google Patents

Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines

Info

Publication number: CA1247082A
Authority: CA; Canada
Prior art keywords: glycoprotein; polypeptide; molecular weight; daltons; approximately
Prior art date: 1984-11-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000495112A

Other languages

English (en)

Inventor

Myron E. Essex

Tun-Hou Lee

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Harvard University

Original Assignee

Harvard University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-11-09

Filing date

1985-11-12

Publication date

1988-12-20

1984-11-09 Priority claimed from US06/670,361 external-priority patent/US4725669A/en

1985-11-12 Application filed by Harvard University filed Critical Harvard University

1988-12-20 Application granted granted Critical

1988-12-20 Publication of CA1247082A publication Critical patent/CA1247082A/fr

Status Expired legal-status Critical Current

Links

241000700605 Viruses Species 0.000 title claims abstract description 17
238000003556 assay Methods 0.000 title abstract description 17
208000015181 infectious disease Diseases 0.000 title abstract description 7
208000000389 T-cell leukemia Diseases 0.000 title abstract 2
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 title abstract 2
102000003886 Glycoproteins Human genes 0.000 claims abstract description 81
108090000288 Glycoproteins Proteins 0.000 claims abstract description 81
210000004027 cell Anatomy 0.000 claims abstract description 44
230000000890 antigenic effect Effects 0.000 claims abstract description 26
210000003296 saliva Anatomy 0.000 claims abstract description 10
210000001744 T-lymphocyte Anatomy 0.000 claims abstract description 7
229920001184 polypeptide Polymers 0.000 claims description 48
108090000765 processed proteins & peptides Proteins 0.000 claims description 48
102000004196 processed proteins & peptides Human genes 0.000 claims description 48
238000000034 method Methods 0.000 claims description 30
238000002360 preparation method Methods 0.000 claims description 6
241000598436 Human T-cell lymphotropic virus Species 0.000 claims description 5
230000003612 virological effect Effects 0.000 claims description 4
210000004698 lymphocyte Anatomy 0.000 claims description 3
230000015572 biosynthetic process Effects 0.000 claims 2
102000012750 Membrane Glycoproteins Human genes 0.000 claims 1
108010090054 Membrane Glycoproteins Proteins 0.000 claims 1
210000004369 blood Anatomy 0.000 abstract description 8
239000008280 blood Substances 0.000 abstract description 8
238000002405 diagnostic procedure Methods 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 description 12
208000030507 AIDS Diseases 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
210000002966 serum Anatomy 0.000 description 10
235000018102 proteins Nutrition 0.000 description 9
239000000427 antigen Substances 0.000 description 8
102000036639 antigens Human genes 0.000 description 8
108091007433 antigens Proteins 0.000 description 8
239000013592 cell lysate Substances 0.000 description 6
208000031886 HIV Infections Diseases 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
230000000694 effects Effects 0.000 description 5
238000001502 gel electrophoresis Methods 0.000 description 5
239000011324 bead Substances 0.000 description 4
238000001514 detection method Methods 0.000 description 4
230000000652 homosexual effect Effects 0.000 description 4
239000002773 nucleotide Substances 0.000 description 4
125000003729 nucleotide group Chemical group 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
239000000463 material Substances 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
210000002845 virion Anatomy 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
208000008771 Lymphadenopathy Diseases 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
241001494479 Pecora Species 0.000 description 2
239000012083 RIPA buffer Substances 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 2
150000001413 amino acids Chemical group 0.000 description 2
239000000872 buffer Substances 0.000 description 2
238000002967 competitive immunoassay Methods 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000010790 dilution Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
239000012634 fragment Substances 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
238000001114 immunoprecipitation Methods 0.000 description 2
108010034897 lentil lectin Proteins 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
208000018555 lymphatic system disease Diseases 0.000 description 2
239000000203 mixture Substances 0.000 description 2
239000013641 positive control Substances 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
229940083575 sodium dodecyl sulfate Drugs 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 description 2
MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
102000003846 Carbonic anhydrases Human genes 0.000 description 1
108090000209 Carbonic anhydrases Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
241000609499 Palicourea Species 0.000 description 1
108010065081 Phosphorylase b Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
230000003302 anti-idiotype Effects 0.000 description 1
239000002543 antimycotic Substances 0.000 description 1
238000000211 autoradiogram Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
229960003964 deoxycholic acid Drugs 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
108010078428 env Gene Products Proteins 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
239000012133 immunoprecipitate Substances 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000006166 lysate Substances 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
150000008146 mannosides Chemical class 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000009966 trimming Methods 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
239000004474 valine Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Landscapes

Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA000495112A 1984-11-09 1985-11-12 Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines Expired CA1247082A (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US670,361		1984-11-09
US06/670,361 US4725669A (en)	1984-11-09	1984-11-09	Assay for detecting infection by human T-cell lymphotropic virus-III
US79597485A	1985-11-07	1985-11-07
US795,974		1991-11-22

Publications (1)

Publication Number	Publication Date
CA1247082A true CA1247082A (fr)	1988-12-20

Family

ID=27100301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000495112A Expired CA1247082A (fr)	1984-11-09	1985-11-12	Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines

Country Status (1)

Country	Link
CA (1)	CA1247082A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7803524B2 (en)	1994-02-23	2010-09-28	Siemens Healthcare Diagnostics Products Gmbh	Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKLIS

1985
- 1985-11-12 CA CA000495112A patent/CA1247082A/fr not_active Expired

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7803524B2 (en)	1994-02-23	2010-09-28	Siemens Healthcare Diagnostics Products Gmbh	Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKLIS

Legal Events

Date	Code	Title	Description
2005-12-20	MKEX	Expiry

Publication	Publication Date	Title
EP0201588B1 (fr)	1995-01-04	Analyse de detection d'une infection par un virus lymphotrophique de cellules t humaines
EP0151579B1 (fr)	1995-09-06	Procede et produits de detection du virus de la leucemie de cellules t humaines
EP0233045B1 (fr)	1995-05-24	Peptides pour le diagnostic des anticorps HTLV-III, ainsi que leur préparation et leur utilisation
US4753873A (en)	1988-06-28	Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
JP2626721B2 (ja)	1997-07-02	Ｈｔｌｖ―３の蛋白質の分離、エイズおよび前エイズ条件を持つ患者の血清中ｈｔｌｖ―３に対する抗体の血清学的検出、およびｈｔｌｖ―３およびその蛋白質を使用した免疫分析によるｈｔｌｖ―３感染の検出
CA1338501C (fr)	1996-07-30	Methode de detection d'anticorps anti-htlv-iii
Lutz et al.	1988	Specificity assessment of feline T‐lymphotropic lentivirus serology
US4743678A (en)	1988-05-10	Method and products for detection of human T cell leukemia virus
US6492104B1 (en)	2002-12-10	EIA test using nondenatured HIV antigen for early detection of HIV infection
US6531574B1 (en)	2003-03-11	T-lymphotrophic virus
Vidal et al.	1997	A solid-phase enzyme linked immunosorbent assay using monoclonal antibodies, for the detection of African swine fever virus antigens and antibodies
US5068174A (en)	1991-11-26	T-cell lymphotrophic virus protein and assay
CA1247082A (fr)	1988-12-20	Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines
CA1283043C (fr)	1991-04-16	Proteine de cellules-t lymphotropes et dosage
EP0453563A1 (fr)	1991-10-30	Proteines de diagnostic utilisees pour tester plus d'un anticorps
US6541609B2 (en)	2003-04-01	HIV-2 peptides
WO1988008449A1 (fr)	1988-11-03	Souche de retrovirus humain apparente au hiv ayant une sequence de nucleotides clones et ses applications
US5045448A (en)	1991-09-03	Method and products for detection of human T cell leukemia virus
JPS63501295A (ja)	1988-05-19	Ｔ−リンパ趨行性ウイルス

CA1247082A - Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines - Google Patents

Info

Links

Landscapes

Applications Claiming Priority (4)

Publications (1)

Family

ID=27100301

Family Applications (1)

Country Status (1)

Cited By (1)

Cited By (1)

Similar Documents

Legal Events